There’s growing concern among lawmakers and advocates about the future of HIV/AIDS services due to potential federal funding cuts.
A recent Republican budget proposal from the House of Representatives aims to slash over $1.5 billion from services for individuals at risk of HIV in the U.S. This figure significantly exceeds the cuts suggested by President Trump and the Senate.
It’s uncertain if the Senate or the White House will back this bill once the government shutdown concludes. Advocates warn that passing these cuts could lead to increased infections and fatalities.
Rep. Rosa DeLauro (D-Conn.), who is the top Democrat on the House Appropriations Committee, described these actions as “callous” in her statements.
“People nationwide depend on resources for testing, access to PrEP, early diagnosis, and life-saving treatments,” she stated.
DeLauro emphasized that cutting these programs isn’t a viable option, echoing the sentiments of many living with HIV.
Javier Muñoz, an actor with HIV, also expressed alarm, stating, “Anyone who remembers the early days of the AIDS epidemic knows the consequences of governmental inaction.” He highlighted that countless lives have been lost and warned, “Protecting current funding is crucial.”
Funding Proposals Clash
The House’s annual budget proposes to cut more than $1 billion from domestic HIV/AIDS prevention and research services. The Ryan White HIV/AIDS Program, which provides treatment support, is also at risk, with a suggested cut of $525 million.
Further reductions included in this bill could result in total cuts of around $2 billion to HIV-related services.
Jeremiah Johnson, the executive director of PrEP4All, commented on the earlier cuts to global HIV programs by the Trump administration which made headlines. He emphasized the immediate impact domestically is only just starting to garner attention.
“These cuts will lead to fewer tests and more deaths from opportunistic infections,” he warned.
Meanwhile, Congressman Mark Pocan (D-Wisconsin) attempted to amend the House bill to prevent $1.4 billion in cuts, but the effort did not succeed along party lines.
Rep. Robert Aderholt (R-Ala.), chair of the Appropriations Subcommittee, acknowledged the tough choices within the bill, but defended the proposed $2 billion investment in Ryan White program funding.
Despite this, Aderholt mentioned that he wouldn’t support Pocan’s amendment, as it lacked a funding offset and might violate budgetary rules.
Aderholt’s statements reflect Republicans trying to adhere to White House directives to reduce overspending. Nevertheless, that doesn’t automatically imply cuts to health care programs.
One instance is the Housing Opportunities for People with AIDS (HOPWA) program, which, despite recommendations for elimination, received $505 million in the House bill.
Contrarily, the Senate passed its own funding bill in September that supports HOPWA and Ryan White funding while allocating significant resources for the CDC to prevent STDs, including HIV/AIDS.
This indicates a certain hesitance in the Senate to reduce HIV/AIDS program funding, with Senate Republicans recognizing the serious implications of such cuts.
Sen. Susan Collins (R-Maine) praised PEPFAR, asserting it as a “huge success” and opposing its removal from funding considerations.
When questioned about the detrimental effects of domestic HIV service cuts, a spokesperson for the Department of Health and Human Services (HHS) stated that critical programs would “continue through the Administration for a Healthy America.” However, proposed changes are still in the conceptual phase, with Congress yet to take any definitive action.
Impact of Proposed Cuts
Advocates have expressed both frustration and dismay at various funding proposals, feeling uncertain about the federal government’s commitment to continuing what had been a bipartisan initiative.
Johnson remarked that there’s a multitude of challenges the community faces, noting a perception that HIV funding is being intentionally targeted at this moment.
Earlier staff cuts at HHS have dismantled vital offices dedicated to HIV services, worsening the situation.
This past summer, significant legislation emerged that threatened to withdraw billions from Medicaid, the largest coverage source for HIV patients in the U.S. Approximately 1.2 million individuals are living with HIV in the country, and many rely on Medicaid for coverage of treatments, particularly important medications like PrEP and newer options.
Lindell Urbano of Amida Care stated that about 40% of adults receiving HIV treatment are supported by Medicaid. He underscored the steep costs of HIV treatments, noting that without Medicaid, many low-income individuals would be unable to afford necessary care.
Urbano warned that if funding cuts proceed, crucial programs for testing, training for healthcare providers, and rural access will likely vanish.
The CDC recently issued updated guidelines on preventive treatment, emphasizing the importance of lenacapavir, a new injectable that offers significant promise for HIV care.
Urbano is concerned that politicization could complicate the approval of essential treatments, lamenting the challenges patients might face to access life-changing medication.
Jenny Collier, CEO of the Collier Collective, shared that uncertainty looms among patients regarding their medication and support services. “People are worried about waiting lists and whether their copays will even be covered,” she said.
Muñoz voiced his worries, saying that without federal aid, he might lose access to critical medications, relying on community resources that depend on government funding.
“Cutting HIV funding literally means death,” he asserted. “That’s not an exaggeration. Such severe cuts have serious consequences for those who rely on life-saving medications.”
